Quidel Cardiovascular initiated a recall in May of its Triage cardiac panel because the assay could indicate inaccurate levels of troponin, a protein that appears in the blood following a myocardial infarction.
News We’re Watching: Quidel Recall, Partnerships For Teladoc And Lifebit, Alaris Cybersecurity Issues
This week, Quidel recalled the Triage cardiac panel due to a risk of false results; Teladoc and Lifebit announced new partnerships; and, a court upheld a false advertising verdict against Natera, but struck the financial penalties.
